This retrospective study used the TriNetX database with propensity score matching to estimate the cumulative incidence of epilepsy in patients with Neurofibromatosis Type 2 (NF2) compared to a matched control population.
The study found a measurably higher cumulative incidence of epilepsy in patients with NF2 relative to propensity-matched controls, though specific absolute numbers and hazard ratios are not available from the provided abstract.
Retrospective database design limits causal inference; TriNetX captures only patients seen within participating health systems, potentially missing undiagnosed or community-managed cases; propensity matching cannot fully control for unmeasured confounders.
Clinicians managing NF2 patients should maintain a heightened index of suspicion for epilepsy and consider routine neurological monitoring. Early identification of seizure activity in this population may improve outcomes.
